CND Life Sciences, NuFactor Educate Neurology Community About Syn-One Test
The Syn-One Test uses a simple skin biopsy to diagnose a group of neurodegenerative diseases called synucleinopathies, which includes Parkinson’s.
Read More
Search Results for: parkinson
Scientists Closer to Developing ‘Game-Changing’ Test to Diagnose Parkinson’s
New research findings offer hope that a new test could be developed to diagnose Parkinson’s through a simple and painless skin swab.
Read More
PerkinElmer Launches No-Wash Immunoassay for Phospho Ubiquitin Ser65
The new kit provides highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s.
Read More
CND Life Sciences Awarded Grant to Advance Diagnostic Technology for Neurodegenerative Diseases
With this grant, CND will support the largest study of its kind to enhance the precision and clinical utility of its Syn-One Test, which is being adopted by neurologists to improve the diagnosis of neurodegenerative disorders, notably Parkinson’s.
Read More
Processing Time a Major Concern for Covid-19 Tests for Long-Term Care
The time required to process covid-19 tests of staff at nursing homes and assisted-living communities is becoming a major concern for providers.
Read More